☆ 4.7 Article

Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study

BLOOD (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Clinical Neurology

Progressive multifocal leukoencephalopathy in dimethyl fumarate-treated multiple sclerosis patients

Allison L. M. Jordan et al.

Summary: Dimethyl fumarate (DMF) is commonly used for treating relapsing multiple sclerosis (MS), but is associated with progressive multifocal leukoencephalopathy (PML). This study provides detailed clinical characteristics of nine PML cases and finds a PML incidence of 0.02 per 1000 DMF-treated patients. Older age and persistent severe lymphopenia are potential risk factors for PML, but younger patients without lymphopenia can also develop PML. Changes in specific subsets of immune cells may be more important than total lymphocyte count in DMF-associated PML. Additionally, the immune profile in cerebrospinal fluid (CSF) may be useful for assessing PML risk in DMF-treated patients.

MULTIPLE SCLEROSIS JOURNAL (2022)

添加到收藏夹

Article Hematology

Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC

Elise A. Olsen et al.

Summary: The number of patients with primary cutaneous lymphoma (PCL) is small compared to other non-Hodgkin lymphomas (NHLs), and there are many subtypes. Clinical trial guidelines for PCL, except for mycosis fungoides/Sezary syndrome, are lacking. To address this gap, international dermatology organizations propose updated staging and guidelines aligned with the Lugano guidelines, aiming to facilitate regulatory approval, encourage cooperative trials, and assess comparative efficacy of therapeutic agents.

BLOOD (2022)

添加到收藏夹

Article Hematology

Resistance to mogamulizumab is associated with loss of CCR4 in cutaneous T-cell lymphoma

Sara Beygi et al.

Summary: Resistance to mogamulizumab in mycosis fungoides and Sezary syndrome is often associated with loss of CCR4 expression and emergence of CCR4 genomic alterations. This finding has significant implications for the management and monitoring of patients receiving mogamulizumab and the development of future CCR4-directed therapies.

BLOOD (2022)

添加到收藏夹

Article Multidisciplinary Sciences

ADAR3 activates NF-κB signaling and promotes glioblastoma cell resistance to temozolomide

Reshma Raghava Kurup et al.

Summary: A study found that elevated expression of ADAR3 in glioblastoma cells promotes NF-kappa B activation and a gene expression program that provides a growth advantage. Aberrant NF-kappa B activation is common in glioblastoma and can impact tumor progression and resistance to treatment.

SCIENTIFIC REPORTS (2022)

添加到收藏夹

Review Hematology

The changing therapeutic landscape, burden of disease, and unmet needs in patients with cutaneous T-cell lymphoma

Julia J. Scarisbrick et al.

Summary: CTCL presents a chronic and relapsing course, impacting patients' HRQoL. Treatment aims to reduce symptoms and halt disease progression, but faces challenges like low level of evidence for treatment recommendations and patients' intolerance to drug side-effects.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Dimethyl fumarate induced lymphopenia in multiple sclerosis: A review of the literature

Cinzia Dello Russo et al.

Summary: Dimethyl fumarate (DMF) is a first line medication for multiple sclerosis, but concerns have been raised regarding its adverse effects such as lymphopenia. The molecular mechanisms underlying these effects are not well understood, and the relative toxicity of DMF and its metabolite MMF in vivo remains unclear.

PHARMACOLOGY & THERAPEUTICS (2021)

添加到收藏夹

Review Dermatology

The importance of assessing blood tumour burden in cutaneous T-cell lymphoma

M. H. Vermeer et al.

Summary: Mycosis fungoides (MF) and Sezary syndrome (SS) are well-studied subtypes of cutaneous T-cell lymphoma. Accurate quantification of blood involvement is crucial for diagnosis, staging, prognosis, and treatment response assessment. Flow cytometry-based classifications are being developed to improve the assessment of blood involvement and treatment response in MF and SS.

BRITISH JOURNAL OF DERMATOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma

Darci Phillips et al.

Summary: This study reveals a spatial biomarker that utilizes immune and cancer cell topography to predict response to PD-1 blockade in cutaneous T cell lymphomas. The biomarker is strongly correlated with the functional immune state of the tumor microenvironment, T cell function, and tumor cell-specific chemokine recruitment.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Review Dermatology

Quality of life in patients with Mycosis Fungoides and Sezary Syndrome: a systematic review of the literature

R. Ottevanger et al.

Summary: This study investigates the impact of Cutaneous T-cell Lymphoma on Quality of Life (QoL) in patients with Mycosis Fungoides and Sezary syndrome, revealing that late-stage disease significantly impairs QoL in terms of functional, emotional, and physical domains. Even patients with limited disease experience mild to moderate effects on QoL, with pruritus being the most frequent and bothersome symptom. The study emphasizes the importance of considering disease stage when addressing QoL deficits in clinical practice.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

添加到收藏夹

Article Biochemical Research Methods

CODEX multiplexed tissue imaging with DNA-conjugated antibodies

Sarah Black et al.

Summary: Advances in multiplexed imaging technologies, such as CODEX, using DNA-conjugated antibodies and fluorescently labeled DNA probes, allow visualization of up to 60 markers simultaneously in tissues. This enables a deep view into single-cell spatial relationships and can drive discovery in developmental biology, disease, and therapeutic design.

NATURE PROTOCOLS (2021)

添加到收藏夹

Article Oncology

Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sezary Syndrome: A Multicenter Phase II Study

Michael S. Khodadoust et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

添加到收藏夹

Review Genetics & Heredity

Role of the NF-κB signaling pathway in the pathogenesis of colorectal cancer

Atena Soleimani et al.

GENE (2020)

添加到收藏夹

Article Medicine, General & Internal

Long-Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T-Cell Lymphoma; Results From a Single Institution Analysis

Florentia Dimitriou et al.

FRONTIERS IN MEDICINE (2020)

添加到收藏夹

Article Oncology

Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma

Auris Huen et al.

CANCERS (2020)

添加到收藏夹

Review Oncology

Allogeneic Hematopoietic Stem Cell Transplantation in Cutaneous T-Cell Lymphomas

Maelle Dumont et al.

CANCERS (2020)

添加到收藏夹

Article Hematology

Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma

Wen-Kai Weng et al.

BLOOD ADVANCES (2020)

添加到收藏夹

Review Chemistry, Medicinal

Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?

Stephanie Kourakis et al.

PHARMACEUTICALS (2020)

添加到收藏夹

Correction Biochemistry & Molecular Biology

Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front (vol 182, pg 1341, 2020)

Christian M. Schurch et al.

CELL (2020)

添加到收藏夹

Article Hematology

Combined inhibition of Bcl-2 and NFκB synergistically induces cell death in cutaneous T-cell lymphoma

Tabea C. Froehlich et al.

BLOOD (2019)

添加到收藏夹

Article Oncology

IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial

Martine Bagot et al.

LANCET ONCOLOGY (2019)

添加到收藏夹

Review Pharmacology & Pharmacy

Dimethyl Fumarate: A Review in Relapsing-Remitting MS

Hannah A. Blair

DRUGS (2019)

添加到收藏夹

Article Hematology

The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas

Rein Willemze et al.

BLOOD (2019)

添加到收藏夹

Article Dermatology

Clinical use of dimethyl fumarate in moderate-to-severe plaque-type psoriasis: a European expert consensus

U. Mrowietz et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)

添加到收藏夹

Article Oncology

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Youn H. Kim et al.

LANCET ONCOLOGY (2018)

添加到收藏夹

Review Oncology

European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sezary syndrome - Update 2017

Franz Trautinger et al.

EUROPEAN JOURNAL OF CANCER (2017)

添加到收藏夹

Article Medicine, General & Internal

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

H. Miles Prince et al.

LANCET (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Targeting Thioredoxin-1 by dimethyl fumarate induces ripoptosome-mediated cell death

Anne Schroeder et al.

SCIENTIFIC REPORTS (2017)

添加到收藏夹

Article Hematology

Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting F-κB

Jan P. Nicolay et al.

BLOOD (2016)

添加到收藏夹

Editorial Material Dermatology

Cutaneous T-cell lymphomas: an urgent need for more improved therapies

J. J. Scari

BRITISH JOURNAL OF DERMATOLOGY (2016)

添加到收藏夹

Article Hematology

Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma

Madeleine Duvic et al.

BLOOD (2015)

添加到收藏夹

Article Oncology

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sezary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model

Julia J. Scarisbrick et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

添加到收藏夹

Article Genetics & Heredity

Genomic analysis of mycosis fungoides and Sezary syndrome identifies recurrent alterations in TNFR2

Alexander Ungewickell et al.

NATURE GENETICS (2015)

添加到收藏夹

Article Hematology

Lack of durable disease control with chemotherapy for mycosis fungoides and Sezary syndrome: a comparative study of systemic therapy

Charlotte F. M. Hughes et al.

BLOOD (2015)

添加到收藏夹

Letter Oncology

Long-Term Outcome of Allogeneic Hematopoietic Cell Transplantation for Patients With Mycosis Fungoides and Sezary Syndrome: A European Society for Blood and Marrow Transplantation Lymphoma Working Party Extended Analysis

Rafael F. Duarte et al.

JOURNAL OF CLINICAL ONCOLOGY (2014)

添加到收藏夹

Article Oncology

NF-κB, an Active Player in Human Cancers

Yifeng Xia et al.

CANCER IMMUNOLOGY RESEARCH (2014)

添加到收藏夹

Article Oncology

Protein Kinase C-β-Dependent Activation of NF-κB in Stromal Cells Is Indispensable for the Survival of Chronic Lymphocytic Leukemia B Cells In Vivo

Gloria Lutzny et al.

CANCER CELL (2013)

添加到收藏夹

Article Immunology

A PP4 Holoenzyme Balances Physiological and Oncogenic Nuclear Factor-Kappa B Signaling in T Lymphocytes

Markus Brechmann et al.

IMMUNITY (2012)

添加到收藏夹

Article Oncology

Clinical End Points and Response Criteria in Mycosis Fungoides and Sezary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer

Elise A. Olsen et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

添加到收藏夹

Article Oncology

Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sezary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal

Nita Sally Agar et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

添加到收藏夹

Article Oncology

Inhibition of Constitutively Activated Nuclear Factor-κB Induces Reactive Oxygen Species- and Iron-Dependent Cell Death in Cutaneous T-Cell Lymphoma

Michael K. Kiessling et al.

CANCER RESEARCH (2009)

添加到收藏夹

Review Hematology

Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)

Elise Olsen et al.

BLOOD (2007)

添加到收藏夹

Article Hematology

Down-regulating constitutive activation of the NF-κB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis

A Sors et al.

BLOOD (2006)

添加到收藏夹

Article Immunology

HIV-1 trans-activator of transcription substitutes for oxidative signaling in activation-induced T cell death

K Gülow et al.

JOURNAL OF IMMUNOLOGY (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.